Document › Details
Metabolon, Inc.. (3/27/12). "Press Release: Metabolon Awarded Analytical Methods Patent". Research Triangle Park, NC.
|Region||United States (USA)|
|Organisation 2||US Patent and Trademark Office (USPTO)|
|Group||United States (govt)|
|Product||data analysis s/w (bioinformatics)|
Metabolon, Inc., a diagnostics and services company offering the industry's leading biochemical profiling technology, announces the grant of US Patent 8,131,473 "Data Analysis Methods for Locating Entities of Interest within Large Multivariable Datasets." The patent was issued on March 6, 2012 and is the sixth technology patent and nineteenth patent overall awarded to Metabolon. The invention describes analysis methods and computational tools developed by Metabolon to quickly and accurately locate biochemicals, genes and proteins of interest in large multivariate data.
The use of genomics, proteomics and metabolomics to answer a variety of biological questions has increased dramatically over the last few years. These 'omics sciences generate massive amounts of data, and sifting through that data to identify biologically significant changes is a major rate-limiting step. The patented method enables the researcher to process, analyze, and interpret data more efficiently. Through the implementation of these techniques, the relevant changes in transcripts, proteins and biochemicals in an experimental sample can be quickly and accurately identified. This enables the interpretation of the results, and facilitates the understanding of biological mechanisms and modes of action.
Metabolon, Inc. has advanced the field of metabolomics by pioneering and patenting the industry's leading biochemical biomarker discovery and profiling platform. It has developed the technology to quickly identify and measure all of the biochemicals in a biological sample through its proprietary global processing method. Through the generation and interpretation of data, this method provides a precise understanding of disease etiology and drug action, and advances personalized medicine beyond what genomics and other approaches can promise. Metabolon's expertise is being embraced by a wide range of pharmaceutical, biotechnology, food and agricultural companies. Metabolytics, its biomarker discovery and analysis business, has completed over 350 client studies and processed over 50,000 samples for customers in 2011 alone. Building on its expertise in biochemistry understanding, Metabolon is also developing proprietary diagnostic tests to determine and track disease progression. For more information about Metabolon, please visit www.metabolon.com or contact Matt Zaske at firstname.lastname@example.org or 919-595-2200.
Record changed: 2016-03-19
More documents for Metabolon (Group)
-  Metabolon, Inc.. (12/5/16). "Press Release: Metabolon Raises Additional $15 Million in Funding from Essex Woodlands". Research Triangle Park, NC....
-  Metabolon, Inc.. (9/28/16). "Press Release: Metabolon Launches Meta IMD Test to Speed Diagnosis of Inherited Metabolic Disorders". Research Triangle Park, NC....
-  Metabolon, Inc.. (8/11/16). "Press Release: Metabolon Closes $15 Million Financing to Support Precision Medicine Growth Opportunities". Research Triangle Park, NC....
-  Muses Labs. (7/13/16). "Press Release: Metabolon and Muses Labs Partner to Apply Metabolomics to Alzheimer’s Disease". Raleigh, NC....
-  Metabolon, Inc.. (3/29/16). "Press Release: Metabolon and Synlab Group Form Commercialization Collaboration for Quantose IR Diagnostic". Research Triangle Park, NC....
-  Metabolon, Inc.. (7/6/15). "Press Release: Darin Leigh Joins Metabolon as Chief Commercial Officer". Research Triangle Park, NC....
-  AB Sciex (d/b/a Sciex). (6/1/15). "Press Release: Sciex and Metabolon Launch the Lipidyzer Platform for Complete Lipid Analysis, from Sample to Biology". Framingham, MA & Research Triangle Park, NC....
-  Metabolon, Inc.. (3/18/15). "Press Release: Study Shows Quantose IR Measures Insulin Sensitivity Better Than A1C Test for Prediabetes". Research Triangle Park, NC....
-  Metabolon, Inc.. (3/5/15). "Press Release: Metabolon Separates Board Chairman & CEO Roles. Independent Director Santo J. Costa Elected Chairman of the Board". Research Triangle Park, NC....
-  Metabolon, Inc.. (9/3/14). "Press Release: Metabolon and Baylor College of Medicine Partner to Launch Global Metabolomic-Assisted Pathway Screen (MAPS) for Inborn Errors of Metabolism". Research Triangle Park, NC & Houston, TX....
To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to email@example.com and simply fill the subject line with the word »MSC newsletter«
To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]